PROPELLER HEALTH

Company Overview

Propeller Health is a wholly owned subsidiary of ResMed. As a leader in digital health and therapeutics for asthma and COPD, the company works to improve clinical outcomes, healthcare costs, and quality of life by supporting patients in managing their condition with their healthcare provider.

Propeller’s platform includes FDA cleared medical devices, consumer apps, and access to clinical data for provider monitoring throughout the care journey, to create value to all stakeholders. Propeller Health enables a personalized digital experience with a human touch used by patients, caregivers, providers, payers, pharmaceutical companies, and other healthcare organizations across the US, Europe, and Asia.

Patients use the Propeller platform by attaching a sensor to their inhaler for asthma or COPD. The sensor tracks medication usage and location data and delivers insights to the patient via a smartphone app. These insights include medication adherence reminders, air quality forecasts, symptom insights, and tips to help them understand and manage their condition. With the patient’s consent, Propeller can communicate to the patient’s physician between appointments and share insights on their disease management.

Propeller has been used by more than 140,000 patients in 16 countries. Propeller is cleared as a class II medical device by the FDA and as a class I medical device in the EU and Canada.

Company's Business Segments

• Digital Health and Therapeutics : The company provides wide range of respiratory care expertise, digital therapeutics care, and platforms to uplift patient lives, clinicians, health systems, payers, and life sciences.